Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy

Min, Sang-Won, Cho, Seo-Hyun, Zhou, Yungui, Schroeder, Sebastian, Haroutunian, Vahram, Seeley, William W., Huang, Eric J., Shen, Yong +6 more·2010·Neuron
DOI 10.1016/j.neuron.2010.08.044

Cited by (959)

Items 701–800 of 959

  1. The Role of Aβ and Tau Oligomers in the Pathogenesis of Alzheimer’s Disease
    Kiran Bhaskar, Bruce T. Lamb · 2011 · Springer eBooks
  2. Tau-based therapies for Alzheimer’s disease: Promising novel neuroprotective approaches
    Carmen Laura Sayas · 2019 · Elsevier eBooks
  3. Disease‐Modifying Treatments for Progressive Supranuclear Palsy
    María Stamelou, Adam L. Boxer · 2015 · Movement Disorders Clinical Practice
  4. Oxidative stress differentially induces tau dissociation from neuronal microtubules in neurites of neurons cultured from different regions of the embryonic Gallus domesticus brain
    Erika Beyrent, George Gomez · 2019 · Journal of Neuroscience Research
  5. Role of saturated fatty acid metabolism in posttranslational modifications of the Tau protein
    Valeria Melissa García-Cruz, Roberto Coria, Clorinda Arias · 2025 · Molecular and Cellular Biochemistry
  6. Advances of therapeutic strategies for Alzheimer’s disease
    Xing Guo, Rui-zhu Yue, Zhen Cui, Shuying Wang, Tian Jia, Wenqiang Li, Wei Zhang, Linlin Shan, Chaokun Li · 2025 · Journal of Neurology
  7. Tau protein: Physiological functions and multifaceted roles in neurodegenerative and psychiatric disorders
    Fei Tang, Junfen Wei, Ma-Li Wong, Peng Lei · 2025 · Genomic psychiatry :
  8. The double‐edged sword effect of HDAC6 in Aβ toxicities
    Kuan‐Chung Cheng, Yu‐Luen Hwang, Hsueh‐Cheng Chiang · 2021 · The FASEB Journal
  9. Patient-derived tau and amyloid-β facilitate long-term depression in vivo: role of tumour necrosis factor-α and the integrated stress response
    Neng‐Wei Hu, Tomáš Ondrejčák, Igor V. Klyubin, Yin Yang, Dominic M. Walsh, Frederick J. Livesey, Michael J. Rowan · 2024 · Brain Communications
  10. Elongator promotes neuritogenesis via regulation of tau stability through acly activity
    Michal Shilian, Aviel Even, Hila Gast, Laurent Nguyen, Miguel Weil · 2022 · Frontiers in Cell and Developmental Biology
  11. The role of ceramide and SEW 2871 in the transcription of enzymes involved in amyloid b precursor protein metabolism in an experimental model of Alzheimer’s disease
    Kinga Czubowicz, Sylwia Wójtowicz, Przemysław Leonard Wencel, Robert Piotr Strosznajder · 2018 · Folia Neuropathologica
  12. Progress in Analysis of Tau Protein
    Linyu Li, Xiaoying Wang · 2020 · Chinese Journal of Analytical Chemistry
  13. Chemoinformatics Analyses of Tau Ligands Reveal Key Molecular Requirements for the Identification of Potential Drug Candidates against Tauopathies
    Luca Pinzi, Annachiara Tinivella, Giulio Rastelli · 2021 · Molecules
  14. Production of O-GlcNAc Modified Recombinant Tau in E. coli and Detection of Ser400 O-GlcNAc Tau In Vivo
    Scott A. Yuzwa, David J. Vocadlo · 2016 · Methods in molecular biology
  15. Lysine-Targeting Inhibitors of Amyloidogenic Protein Aggregation: A Promise for Neurodegenerative Proteinopathies
    Kazuma Murakami, Thi Hong Van Nguyen, Chioko Nagao, Kenji Mizuguchi, Gal Bitan · 2025 · JACS Au
  16. Illuminating Tau Aggregates: Multiscale Approaches for Detection, Imaging, and Understanding
    Kaustubh R. Bhuskute, Jiayi Fan, Amandeep Kaur · 2025 · Aggregate
  17. Acetylation Mimetic and Null Mutations Within the Filament Core of P301L Tau Have Varied Effects on Susceptibility to Seeding and Aggregation
    Ethan D. Smith, Jose Torrellas, Robert McKenna, Quan Vo, Mario Mietzsch, David Borchelt, Stefan Prokop, Paramita Chakrabarty · 2025 · Journal of Neurochemistry
  18. Advancement of disease-modifying therapy of Alzheimer’s disease: from the perspective of new revised criteria for diagnosis and staging of Alzheimer’s disease
    Jie Wu, Chao-Fan Geng, Liyang Liu, Yi Tang · 2025 · Medicine Plus
  19. Stable ubiquitin conjugation for biological interrogation of ubiquitinated tau repeat domain
    Giovanna Viola, Daniele Trivellato, Lorenzo Meulli, Roberto Tira, Angela Lauriola, Francesca Munari, Martina Montagnana, Mario Buffelli, Michael Assfalg, Mariapina D’Onofrio · 2024 · Bioorganic Chemistry
  20. Tau regulates Arc stability in neuronal dendrites via a proteasome-sensitive but ubiquitin-independent pathway
    Dina W. Yakout, Ankit Shroff, Wei Wei, Vishrut S. Thaker, Zachary D. Allen, Mathew Sajish, Taras Y. Nazarko, Angela M. Mabb · 2024 · Journal of Biological Chemistry
  21. Yet Another Role for SIRT1: Reduction of α-Synuclein Aggregation in Stressed Neurons
    Nynke Oosterhof, Dorine W. Dekens, Tjitske F Lawerman, Mirjan van Dijk · 2012 · Journal of Neuroscience
  22. A Review on Current Strategies and Future Perspective in Respect to Alzheimer’s Disease Treatment
    Souravh Bais, Renu Kumari, Yash Prashar · 2015 · Current Research in Neuroscience
  23. Controversial Impact of Sirtuins in Chronic Non-Transmissible Diseases and Rehabilitation Medicine
    Alessia Mongelli, Carlo Gaetano · 2018 · International Journal of Molecular Sciences
  24. Identification of potent histone deacetylase 2 (HDAC2) inhibitors through combined structure and ligand-based designs and molecular modelling approach
    Asha Anand, Powsali Ghosh, Ravi Singh, Nilesh Gajanan Bajad, Ashok Kumar, Sushil Kumar Singh · 2023 · Journal of Biomolecular Structure and Dynamics
  25. Effects of task-specific rehabilitation training on tau modification in rat with photothrombotic cortical ischemic damage
    Kyung‐Lim Joa, Sohee Moon, Ji-Hye Kim, Dong Wun Shin, Kyoung‐Hee Lee, Seon Ho Jung, Myeong-Ok Kim, Chang-Hwan Kim, Han Young Jung, Ju‐Hee Kang · 2017 · Neurochemistry International
  26. SIRT1: A Novel Way to Target Tau?
    Hunter S. Futch, Cara L. Croft · 2018 · Journal of Neuroscience
  27. Tau Protein Associated Inhibitors in Alzheimer Disease
    Qianqian Li, Tingting Chu, Yong‐Xiang Chen, Yanmei Li · 2014 · Chinese Journal of Chemistry
  28. Precision Medicine in Neurodegenerative Diseases: Genomic Approaches to Target Amyloid-β, Tau, and Alpha-Synuclein Pathways
    Zaid Waqar, Pranshul Sethi, Divya Jain, Kuldeep Singh, Omar Awad Alsaidan, Sami Ibrahim Alzarea, Jeetendra Kumar Gupta, Swati Saxena, Mukesh Chandra Sharma · 2025 · Current Genomics
  29. Systematic Review on Neurotoxic Implications of Lead-Induced Gene Expression Alterations in the Etiology of Alzheimer’s Disease
    Aluru Parithathvi, P. Harshitha, Kamalesh Dattaram Mumbrekar, Herman Sunil Dsouza · 2025 · Cellular and Molecular Neurobiology
  30. Advances in Alzheimer’s disease: mechanistic insights and therapeutic targets
    Yu-Juan Jia, Yi‐Jun Ge, Bowei Li, Ying Yang, Huaqiu Chen, Jie Liu, Junhong Guo, Jin‐Tai Yu, Keqiang Ye, Jian‐Zhi Wang et al. · 2026 · Science China Life Sciences
  31. An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration
    Madison I. J. Honey, Yanaika S. Hok‐A‐Hin, Elisabeth H. Thijssen, Katheryn A Q Cousins, Babette van der Weijden, Lisanne in ‘t Veld, Erik Stoops, Sterre C.M. de Boer, Flora Hillegonde Duits, Julie F. H. De Houwer et al. · 2026 · Nature Medicine
  32. Integrating network pharmacology and experimental validation to investigate the effects and mechanism of Renshen Shouwu decoction for ameliorating Alzheimer’s disease
    Jingjing Liu, Jian-bo Yang, Ying Wang, Xiao-Ru Hu, Ya-Dan Wang, Lixing Nie, Feng Wei, Jiandong Yu, Lingwen Yao, Beilei Xu et al. · 2024 · Pharmaceutical Biology
  33. Making tau amyloid models in vitro: a crucial and underestimated challenge
    Julien Broc, Clara Piersson, Yann Fichou · 2025 · FEBS Letters
  34. Acetylated tau: A missing link between head injury and dementia
    Zhen Zhao, Berislav V. Zloković · 2021 · Med
  35. Hippocampal SIRT1 improves cognitive impairment by deacetylating tau protein in diabetic models
    Naihao Shi, Yuwen Lin, Binbin Yan, Xiaowei Jiao, Xiaobao Ding, Yuqing Wu, Chenghua Zhou · 2021 · European Journal of Pharmacology
  36. Identification of a reciprocal negative feedback loop between tau-modifying proteins MARK2 kinase and CBP acetyltransferase
    Zarin Tabassum, Jui‐Heng Tseng, Camryn Isemann, Xu Tian, Youjun Chen, Laura E. Herring, Todd J. Cohen · 2022 · Journal of Biological Chemistry
  37. The current state of amyloidosis therapeutics and the potential role of fluorine in their treatment
    Meghna Dabur, Joana A. Loureiro, Maria do Carmo Pereira · 2022 · Biochimie
  38. Potential Therapeutic Strategies to Prevent the Progression of Alzheimer to Disease States
    Ester Aso, Isidró Ferrer · 2013 · InTech eBooks
  39. Bad Ac-etylated Tau
    Jane C. Hettinger, John R. Cirrito · 2016 · Neuron
  40. Sirtuin Modulation as Novel Neuroprotective Strategy for Alzheimer’s Disease
    Letizia Polito, Gloria Biella, Diego Albani · 2017 · Elsevier eBooks
  41. Acetylation of tubulin: A feasible protective target from neurodevelopment to neurodegeneration
    Cappelletti Graziella, Daniele Cartelli · 2019 · Elsevier eBooks
  42. Effects of Aerobic Exercise on Tau and Related Proteins in Rats with Photochemically-Induced Infarction
    Kyung‐Lim Joa, Sakulrat Mankhong, Sujin Kim, Sohee Moon, Kyoung‐Hee Lee, Young-Hwan Yoo, Byeong-Hun Hwang, Jong-Won Baek, Ju‐Hee Kang · 2020 · Journal of Alzheimer s Disease
  43. Antisense Oligonucleotide-Mediated Reduction of HDAC6 Does Not Reduce Tau Pathology in P301S Tau Transgenic Mice
    Antonio Valencia, Veronica L. Reinhart Bieber, Bekim Bajrami, Galina Marsh, Stefan Hamann, Ru Wei, Karen Ling, Frank Rigo, H. Moore Arnold, Olga Golonzhka et al. · 2021 · Frontiers in Neurology
  44. The Essential Role of Epigenetic Modifications in Neurodegenerative Diseases with Dyskinesia
    Zhipeng Qi, Jiashuo Li, Minghui Li, Xianchao Du, Lei Zhang, Shuang Wang, Bin Xu, Wei Liu, Zhaofa Xu, Yu Lin Deng · 2021 · Cellular and Molecular Neurobiology
  45. Macrocyclic Octapeptide Binding and Inferences on Protein Substrate Binding to Histone Deacetylase 6
    Paris R. Watson, Suchetana Gupta, Parisa Hosseinzadeh, Benjamin P. Brown, David A. Baker, David W. Christianson · 2023 · ACS Chemical Biology
  46. Frontotemporal dementia
    Eline Wauters, Kristel Sleegers, Marc Cruts, Christine Van Broeckhoven · 2017 · Elsevier eBooks
  47. Aging and Neurodegeneration
    Gizem Dönmez · 2013 · Journal of Molecular and Genetic Medicine
  48. Intra-axonal Nanomagnetic Forces Differentially Impact hTau40 Transport Dynamics in Primary Cortical and Hippocampal Neurons
    Mackenna K. Landis, Anja Kunze · 2025 · ACS Nano
  49. The advances in acetylation modification in senescence and aging-related diseases
    Maiqi Xu, Wenbin Wang, Saien Lu, Mengyao Xiong, Tong Zhao, Yao Yu, Chunyu Song, Jinjing Yang, Naijin Zhang, Liu Cao et al. · 2025 · Frontiers in Physiology
  50. Genetic code expansion and enzymatic modifications as accessible methods for studying site‐specific post‐translational modifications of alpha‐synuclein and tau
    Ibrahim G. Saleh, Marie Shimogawa, Jennifer Ramirez, Bernard Abakah, Yarra Venkatesh, Honey Priya James, Minghao Li, Sarah A. Louie, Marshall G. Lougee, Wai‐Kit Chia et al. · 2025 · Protein Science
  51. Targeted tau protein degradation: a promising therapeutic approach for tauopathies
    Narjes Baazaoui, Mohammad Yahya Alfaifi, Ali Abdullah Shati, Rania Ben Saad, Stefanıa Garzoli · 2025 · Neuroscience
  52. Global analysis of lysine acetylation in the brain cortex of K18‐hACE2 mice infected with SARS‐CoV‐2
    Qiaochu Wang, Wanjun Peng, Yehong Yang, Yue Wu, Rong Han, Tao Ding, Xutong Zhang, Jiangning Liu, Jiangfeng Liu, Juntao Yang · 2023 · PROTEOMICS
  53. The Ratio of Plasma Amyloid-β 1-42 over Serum Albumin Can Be a Novel Biomarker Signature for Diagnosing End-Stage Renal Disease-Associated Cognitive Impairment
    Yi‐Chou Hou, Ti-I Chueh, Kuo‐Cheng Lu, Yi‐Chien Liu, Tso-Hsiao Chen, Shing‐Hwa Liu, Ruei‐Ming Chen · 2024 · Journal of Alzheimer s Disease
  54. Sp4/HD11 and Sp1/HAT-p300 complexes induce apoptotic cell death in CuCl2-treated neurons by modulating histone acetylation on BCL-W and BAX promoters
    Silvia Ruggiero, Natascia Guida, Luigi Mascolo, Angelo Serani, Anna Ferrante, Francesca Galasso, Luca Sanguigno, Erica Piemonte, Elvira De Rosa, Paolo Montuori et al. · 2025 · Neurochemistry International
  55. Proteomic Approaches to Unraveling the RB/E2F Regulatory Pathway
    Jone Mitxelena, Nerea Osinalde, Jesus M., Asier Fullaondo, Ana M. · 2012 · InTech eBooks
  56. Meeting report on the Alzheimer’s Drug Discovery Foundation 14th International Conference on Alzheimer’s Drug Discovery
    Lauren G. Friedman, Katherine Ann Price, Rachel F. Lane, Aaron J. Carman, Penny A. Dacks, Diana W. Shineman, Howard M. Fillit · 2014 · Alzheimer s Research & Therapy
  57. Catalytic-independent neuroprotection by SIRT1 is mediated through interaction with HDAC1
    Jason A. Pfister, Chi Ma, Santosh R. D’Mello · 2019 · PLoS ONE
  58. Tauopathy
    Hao Chi, Tzu‐Kang Sang, Hui-Yun Chang · 2019 · IntechOpen eBooks
  59. Tau Fibrillogenesis
    Nitin Chaudhary, Ramakrishnan Nagaraj · 2012 · Sub-cellular biochemistry/Subcellular biochemistry
  60. Neuropathological Outcomes of Traumatic Brain Injury and Alcohol Use in Males and Females: Studies Using Pre-Clinical Rodent and Clinical Human Specimens
    Joshua Schwartzenburg, Shealan C. Cruise, Ryan E. Reed, C. M. Hutchinson, Oygul Mirzalieva, Kimberly N. Edwards, Scott Edwards, Nicholas W. Gilpin, Patricia E. Molina, Shyamal D. Desai · 2023 · Journal of Neurotrauma
  61. Minimotifs dysfunction is pervasive in neurodegenerative disorders
    Surbhi Sharma, Richard J. Young, Jingchun Chen, Xiangning Chen, Edwin C. T. Oh, Martin R. Schiller · 2018 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  62. SUMO inhibits Tau aggregation in Alzheimer’s disease
    Subashchandrabose Chinnathambi, Nagaraj Rangappa · 2025 · Advances in protein chemistry and structural biology
  63. Tau seeding activity in Alzheimer's disease: Characteristics, factors, and applications
    Yajie Liu, Yuxiong Chen, Ziyi Chen, Hao Wan, Chengsi Wu · 2025 · Journal of Alzheimer s Disease
  64. Therapeutic potential of third molar-derived dental pulp stem cells in Alzheimer’s disease: Current evidence and future directions
    Pooja Wagaskar, Meghraj Vivekanand Suryawanshi, Ashwani Patil, Vaishnavi Pardeshi · 2025 · Ageing Research Reviews
  65. Structure of ATTRv-F64S fibrils isolated from skin tissue of a living patient
    Jun Yu, Xuefeng Zhang, Sandra Pinton, Elena Vacchi, Andrea Cavalli, Matteo Pecoraro, Giorgia Melli, Andreas Boland · 2025 · Nature Communications
  66. Epigenetic Modulation Is a Key Mechanism in Cognitive Deficit: Unveiling Garcinol as a Potent HAT Inhibitor in Improving Alzheimer’s Disease
    Abhishek Mishra, Bhabani Sankar Satapathy, Pratap Kumar Sahu, Aruna Ghose, Sudhir Kumar Paidesetty · 2026 · ACS Omega
  67. Post-translational modifications as a regulatory code for tau function in health and disease
    Abigail J. Nordbeck, Bhirisha Sharma, Charles A. Garcia, Jui‐Heng Tseng · 2026 · Frontiers in Dementia
  68. Mechanistic Insights into the Inhibitory and Destabilizing Effects of K353 Acetylation on Tau Peptides and Protofibrils
    Jiaxing Tang, Feng Wang, Zhengdong Xu, Yu Feng Zou, Qingwen Zhang · 2025 · The Journal of Physical Chemistry B
  69. Stimulation of Tau Degradation
    Rodrigo A. Quintanilla, Fabian Cabezas-Opazo, Susanne P. Pallo, Adrianne S. Chesser, Gail V.W. Johnson · 2016 · Elsevier eBooks
  70. Molecular Pathways in Alzheimer’s Disease and Cognitive Function
    Xu Chen, Meredith C. Reichert, Li Gan · 2016 · Elsevier eBooks
  71. The α-Tubulin Deacetylase HDAC6 in Aggresome Formation and Autophagy
    Christiane Richter‐Landsberg · 2015 · Elsevier eBooks
  72. Neurodegenerative Diseases and the Aging Brain
    Stephen K. Godin, Jinsoo Seo, Li‐Huei Tsai · 2018 · Elsevier eBooks
  73. Immunotherapeutics for AD: A Work in Progress
    Anuja Sharma, Jaspreet Singh Anand, Yatender Kumar · 2021 · CNS & Neurological Disorders - Drug Targets
  74. Sirtuins, healthspan, and longevity in mammals
    Surinder Kumar, William Giblin, David B. Lombard · 2021 · Elsevier eBooks
  75. Tau protein aggregation: A therapeutic target for neurodegenerative diseases
    Aryan Duggal, Drishti Mahindru, Kirti Baghel, Sanjana Mehrotra, Vijay Kumar Prajapati · 2025 · Advances in protein chemistry and structural biology
  76. Lysine acetylation modulates s‐ OPA1 GTPase activity and oligomerization in mitochondrial membrane remodeling
    Javaid Jabbar, Bakht Afroze, Naomi X.Y. Ling, Jonathan S. Oakhill, Isabelle Rouiller · 2025 · Protein Science
  77. Concussive injuries induce neuronal stress-dependent tau mislocalization to dendritic spines with acrolein and functional network alteration in TBI-on-a-chip
    Edmond A. Rogers, Tyler C. Diorio, Timothy Beauclair, Jhon Martinez, Shatha J. Mufti, David Kim, Nikita Krishnan, Vitaliy L. Rayz, Riyi Shi · 2025 · Lab on a Chip
  78. A high-throughput drug screening assay for anti-tau aggregation using split GFP and flow cytometry
    Omnia M. H. Ibrahium, Taiwo Ademola Ademoye, Jessica S. Fortin, Raluca Ostafe · 2025 · Scientific Reports
  79. Aerobic exercise facilitates p300 nuclear translocation via ADRB2-AMPKα signaling, leading to enhanced histone acetylation and mitigation of cognitive decline in APP/PS1 mice
    Gao-shang Chai, Tian-long Gao, Shu-guang Bi, Yu-ming Mao, Liu Yang, Fang-Zhou Wang, Jia Chen, Jia-jun Wu, Juan Gong, Shan Geng et al. · 2026 · Alzheimer s Research & Therapy
  80. Sex-specific effects of acetylation on tauopathy in aging htau mice
    Usman Sabir, Bovinari Alistair Csubak, Serguei Ilchenko, MOHAMMAD YUNUS KHALIL ANSARI, Nicholas M. Kanaan, Tsung‐Heng Tsai, Dasarathy Srinivasan, Christine M. Dengler-Crish, Takhar Kasumov · 2026 · Scientific Reports
  81. RNA-based therapeutics for Alzheimer’s disease and related tauopathies: challenges and opportunities
    Binita Rajbanshi, Ilaria Brentari, Michela A. Denti, Jeffrey L. Cummings, Anuj Guruacharya · 2026 · The Journal of Prevention of Alzheimer s Disease
  82. Bioenergetic impairment-induced Tau acetylation: Converging pathways in Alzheimer’s disease
    Basavaraju K C, Poornima Priyadarshini C. G. · 2026 · International review of neurobiology
  83. Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease
    J Lee, Emily Olafson, Balazs Toth, Ellen Casavant, Stephen P. Schauer, Tobias Bittner, Matthew R. Meyer, Philip B. Verghese, Venky Venkatesh, Tim West et al. · 2026 · Alzheimer s & Dementia
  84. Molecular and environmental drivers of tau post-translational modifications and tau pathology
    Trevor M. Price, Autumn E. Tucker, Kristen E. Funk · 2026 · Ageing Research Reviews
  85. Decoding lactate signals in Alzheimer’s disease: redox control, receptor pharmacology, lactylation chemistry, and neuroglial vulnerability
    Wajid Zaman, Asma Ayaz, Aziz Ullah · 2026 · Biochemical Pharmacology
  86. Protein aggregation in health and disease: A looking glass of two faces
    Guilherme Caldas de Andrade, Michelle F. Mota, Dinarte N Moreira-Ferreira, Jerson Lima Silva, Guilherme A. P. de Oliveira, Mayra A. Marques · 2024 · Advances in protein chemistry and structural biology
  87. microRNAs Mediate Signaling Pathways in Alzheimer’s Disease: Biomarkers and Therapeutic Targets
    Ameneh Rezayof, Zahra Ghasemzadeh, Fatemeh Kouhkan · 2024 · Springer eBooks
  88. Conformation pattern changes in R1-pS262 tau peptide induced endogenous tau aggregation, synaptic damage, and cognitive impairments
    Gang Wu, Yong Luo, Qian Guo, Mingming Yang, Yacoubou Abdoul Razak Mahaman, Yi Liu, Jian‐Zhi Wang, Rong Liu, Xiang Gao, Xiaochuan Wang · 2024 · Journal of Alzheimer s Disease
  89. Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?
    Ashi Mannan, Akhil Sharma, Thakur Gurjeet Singh · 2025 · Molecular Neurobiology
  90. Contribution of Multivesicular Bodies to the Prion-Like Propagation of Lesions in Alzheimer’s Disease
    Valérie Vingtdeux, Luc Buée, Nicolas Sergeant · 2011 · InTech eBooks
  91. Protein Lysine Acylation: Abundance, Dynamics and Function
    Olga Pougovkina, Vincent C. J. de Boer · 2016 · Springer eBooks
  92. Protein Misfolding, Neurodegeneration and Tau
    Pierfausto Seneci · 2015 · Elsevier eBooks
  93. Frontotemporal lobar degeneration
    Boram Kim, Ashley Viera-Ortiz, Jessica M. Phan, David John Irwin, Edward B. Lee · 2022 · Elsevier eBooks
  94. Sirtuin functions in the brain: From physiological to pathological aspects
    Jiaxiang Shao, Tingting Zhang, Tengyuan Liu, Yizhou Quan, Li Fan, Jie Liu, Xiao Yi Yang, Qian Reuben Xie, Weiliang Xia · 2014 · Journal of Shanghai Jiaotong University (Science)
  95. Preclinical models of Alzheimer’s disease for identification and preclinical validation of therapeutic targets: from fine-tuning strategies for validated targets to new venues for therapy
    Bruno Vasconcelos, Matthew Bird, Ilie‐Cosmin Stancu, Dick Terwel, Ilse Dewachter · 2017 · Elsevier eBooks
  96. Sirtuins in the biology of aging
    Mateusz Wątroba, Dariusz Szukiewicz · 2021 · Elsevier eBooks
  97. The role of protein phosphatase 2A tau axis in traumatic brain injury therapy
    Maibouge Tanko Mahamane Salissou, Yacoubou Abdoul Razak Mahaman, Xiaochuan Wang, Rabiu Abdussalam Magaji · 2022 · Beni-Suef University Journal of Basic and Applied Sciences
  98. Contributions of AMP kinase to the Pathogenesis of Type 2 Diabetes and Neurodegenerative Diseases
    Mohamed Kodiha, Hicham Mahboubi, Ursula Stochaj · 2013 · Wiley eBooks
  99. Levosimendan prevents tau pathology by inhibiting disulfide-linked tau oligomerization posing as a promising anti-tau therapeutics
    Yun Kyung Kim, Sungsu Lim, Seulgi Shin, Ha Eun Lee, Ji Yeon Song, Yoonsik Sung, Gwan‐Ho Lee, Byung-Yong Yu, Hira Aziz, Nataliia Lukianenko et al. · 2020
  100. Chemical screens in aging-relevant human motor neurons identify MAP4Ks as therapeutic targets for amyotrophic lateral sclerosis
    Menglu Liu, Shuaipeng Ma, Wenjiao Tai, Xiaoling Zhong, Haoqi Ni, Yuhua Zou, Jingcheng wang, Chun‐Li Zhang · 2023 · bioRxiv (Cold Spring Harbor Laboratory)